These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 6419422

  • 1. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei PM, Ho M, Mugambi M, Timms GL, French M.
    Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to haemorrhagic fever viruses in Madagascar populations.
    Mathiot CC, Fontenille D, Georges AJ, Coulanges P.
    Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
    [Abstract] [Full Text] [Related]

  • 3. Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates.
    Johnson BK, Gitau LG, Gichogo A, Tukei PM, Else JG, Suleman MA, Kimani R, Sayer PD.
    Trans R Soc Trop Med Hyg; 1982; 76(3):307-10. PubMed ID: 6810518
    [Abstract] [Full Text] [Related]

  • 4. Viral hemorrhagic fever antibodies in Nigerian populations.
    Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB.
    Am J Trop Med Hyg; 1988 Mar; 38(2):407-10. PubMed ID: 3128130
    [Abstract] [Full Text] [Related]

  • 5. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations.
    Gonzalez JP, Josse R, Johnson ED, Merlin M, Georges AJ, Abandja J, Danyod M, Delaporte E, Dupont A, Ghogomu A.
    Res Virol; 1989 Mar; 140(4):319-31. PubMed ID: 2505350
    [Abstract] [Full Text] [Related]

  • 6. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa.
    Van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC.
    Trop Geogr Med; 1986 Sep; 38(3):209-14. PubMed ID: 3092415
    [Abstract] [Full Text] [Related]

  • 7. Viral haemorrhagic fever surveillance in Kenya, 1980-1981.
    Johnson BK, Ocheng D, Gitau LG, Gichogo A, Tukei PM, Ngindu A, Langatt A, Smith DH, Johnson KM, Kiley MP, Swanepoel R, Isaacson M.
    Trop Geogr Med; 1983 Mar; 35(1):43-7. PubMed ID: 6684336
    [Abstract] [Full Text] [Related]

  • 8. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B, Duquesnoy P, Languillat G, Saluzzo JF, Georges A, Gonzalez JP, McCormick J.
    Trans R Soc Trop Med Hyg; 1982 Mar; 76(6):719-20. PubMed ID: 7164137
    [Abstract] [Full Text] [Related]

  • 9. [Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man].
    Nakounné E, Selekon B, Morvan J.
    Bull Soc Pathol Exot; 2000 Jan; 93(5):340-7. PubMed ID: 11775321
    [Abstract] [Full Text] [Related]

  • 10. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren.
    Blackburn NK, Searle L, Taylor P.
    Trans R Soc Trop Med Hyg; 1982 Jan; 76(6):803-5. PubMed ID: 6761909
    [No Abstract] [Full Text] [Related]

  • 11. [Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon].
    Paix MA, Poveda JD, Malvy D, Bailly C, Merlin M, Fleury HJ.
    Bull Soc Pathol Exot Filiales; 1988 Jan; 81(4):679-82. PubMed ID: 3064937
    [Abstract] [Full Text] [Related]

  • 12. Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984.
    Rodhain F, Gonzalez JP, Mercier E, Helynck B, Larouze B, Hannoun C.
    Trans R Soc Trop Med Hyg; 1989 Jan; 83(6):851-4. PubMed ID: 2559514
    [Abstract] [Full Text] [Related]

  • 13. The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses.
    Mattiuzzo G, Bentley EM, Page M.
    Viruses; 2019 Aug 24; 11(9):. PubMed ID: 31450611
    [Abstract] [Full Text] [Related]

  • 14. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.
    Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S.
    J Clin Microbiol; 2002 Jul 24; 40(7):2323-30. PubMed ID: 12089242
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria.
    Bukbuk DN, Fukushi S, Tani H, Yoshikawa T, Taniguchi S, Iha K, Fukuma A, Shimojima M, Morikawa S, Saijo M, Kasolo F, Baba SS.
    Trans R Soc Trop Med Hyg; 2014 Dec 24; 108(12):768-73. PubMed ID: 25344695
    [Abstract] [Full Text] [Related]

  • 16. Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses.
    Swanepoel R, Struthers JK, McGillivray GM.
    Am J Trop Med Hyg; 1983 May 24; 32(3):610-7. PubMed ID: 6407347
    [Abstract] [Full Text] [Related]

  • 17. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers].
    Lukashevich IS, van der Groen G.
    Vopr Virusol; 1985 May 24; 30(5):624-6. PubMed ID: 3907144
    [No Abstract] [Full Text] [Related]

  • 18. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM, Elliott LH, Heymann DL.
    J Clin Microbiol; 1981 Nov 24; 14(5):527-9. PubMed ID: 7031084
    [Abstract] [Full Text] [Related]

  • 19. Undiagnosed acute viral febrile illnesses, Sierra Leone.
    Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN.
    Emerg Infect Dis; 2014 Jul 24; 20(7):1176-82. PubMed ID: 24959946
    [Abstract] [Full Text] [Related]

  • 20. Update: management of patients with suspected viral hemorrhagic fever--United States.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1995 Jun 30; 44(25):475-9. PubMed ID: 7783731
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.